wide
express
plasma
membran
protein
implic
varieti
physiolog
patholog
activ
best
known
abil
function
extracellular
matrix
metalloproteinas
induc
henc
name
protein
emmprin
also
shown
regul
lymphocyt
respons
monocarboxyl
transport
express
spermatogenesi
function
reflect
multipl
interact
partner
among
protein
cyclophilin
repres
particularli
interest
class
term
structur
consider
potenti
medic
implic
shown
function
cyclophilin
activ
show
signific
antiinflammatori
effect
experiment
model
suggest
interact
may
good
target
new
antiinflammatori
therapeut
review
recent
literatur
differ
aspect
interact
role
inflammatori
diseas
leucocyt
traffick
recruit
critic
compon
inflammationmedi
patholog
main
regul
leucocyt
traffick
chemokin
famili
chemoattract
cytokin
control
cell
migrat
adhes
howev
factor
particular
extracellular
cyclophilin
also
induc
potent
chemotact
respons
immun
cell
review
other
observ
secret
cyclophilin
cypa
potent
leucocyt
chemoattract
vitro
addit
cypa
also
shown
elicit
inflammatori
respons
character
rapid
influx
leucocyt
inject
vivo
base
potent
chemotact
properti
cyclophilin
propos
sever
year
ago
extracellular
cyclophilin
might
contribut
directli
leucocyt
recruit
inflammatori
respons
therebi
complement
chemokin
innat
immun
factor
studi
aim
establish
mechan
wherebi
cyclophilin
mediat
chemotact
activ
group
first
identifi
princip
signal
receptor
extracellular
cyclophilin
inde
human
mous
leucocyt
examin
date
requir
express
extracellular
cyclophilindepend
chemotaxi
occur
recent
publish
review
cover
function
health
diseas
review
focu
upon
interact
overview
role
interact
might
play
diseas
patholog
wide
express
integr
plasma
membran
glycoprotein
character
varieti
name
differ
speci
antigen
rat
basigin
mice
neurothelin
antigen
chicken
human
protein
first
discov
biswa
colleagu
tumour
cellderiv
factor
stimul
product
collagenas
matrix
metalloproteinas
type
fibroblast
design
tumour
cellderiv
collagenas
stimulatori
factor
tcsf
later
found
tcsf
express
cancer
cell
also
normal
cell
human
protein
describ
studi
hbasigin
becom
better
known
name
extracellular
matrix
metalloproteinas
induc
emmprin
properti
protein
studi
extens
consist
review
refer
protein
recent
adopt
design
express
vari
level
mani
cell
type
includ
haematopoiet
epitheli
endotheli
cell
upregul
markedli
earli
erythroblast
heart
placenta
thyroid
tissu
human
amino
acidlong
protein
belong
type
integr
membran
protein
famili
predict
molecular
mass
kda
ntermin
extracellular
part
consist
two
immunoglobulin
ig
like
domain
heavili
glycosyl
endoglycosidas
f
treatment
lead
mobil
shift
kda
kda
approxim
suggest
major
glycosyl
nlink
recent
anoth
form
contain
addit
extracellular
membranedist
iglik
domain
character
form
shown
respons
major
homophil
interact
phylogenet
molecul
trace
invertebr
organ
far
back
drosophila
schistosoma
compar
member
immunoglobulin
superfamili
place
separ
lineag
neighbour
cluster
much
understand
function
come
studi
knockout
mice
anim
defect
lymphocyt
respons
spermatogenesi
retin
neurolog
function
earli
stage
develop
femal
mice
defici
infertil
due
failur
femal
reproduct
process
includ
implant
fertil
implant
defect
may
indic
misregul
mmp
product
anim
also
show
dramat
reduct
accumul
monocarboxyl
transport
mct
protein
retin
pigment
epithelium
support
propos
role
target
transport
plasma
membran
delet
basolater
membran
retin
pigment
epithelium
result
sever
diminish
express
confirm
function
import
interact
regul
express
interestingli
posit
retin
lactat
transport
appear
regul
rare
domain
form
cdna
form
identifi
human
mous
retina
addit
knockout
mice
character
enhanc
mitogen
respons
lymphocyt
mix
lymphocyt
reaction
suggest
potenti
neg
regulatori
function
cell
activ
support
neg
regulatori
role
recent
studi
overexpress
jurkat
cell
demonstr
inhibit
nuclear
factoractiv
cell
nfat
mediat
cell
activ
convers
increas
activ
silenc
via
signal
pathway
howev
anoth
studi
express
silenc
jurkat
cell
show
reduct
rather
increas
cell
activ
reason
discrep
unknown
although
note
first
studi
focus
upon
chang
intracellular
signal
pathway
second
measur
chang
cell
function
interestingli
author
signal
studi
report
inhibit
nfat
activ
mediat
exclus
intracellular
tail
particip
either
extracellular
transmembran
region
thu
variabl
outcom
studi
could
due
differ
function
paramet
regul
distinct
region
measur
addit
support
neg
regulatori
role
cell
activ
provid
vitro
studi
monoclon
antibodi
mab
shown
inhibit
activ
mediat
phorbol
myrist
acet
pma
ionomycin
human
peripher
blood
cell
cell
line
observ
effect
function
natur
clone
signal
capac
must
select
altern
antibodi
could
mediat
effect
hinder
steric
certain
interact
molecul
ligand
includ
signal
partner
within
membran
lipid
raft
adhes
partner
cell
surfac
andor
solubl
partner
extracellular
microenviron
see
second
player
chemotact
pathway
extracellular
cyclophilin
cyclophilin
best
known
ubiquit
distribut
intracellular
protein
first
recogn
host
cell
receptor
potent
immunosuppress
drug
cyclosporin
csa
studi
date
focus
upon
intracellular
activ
cyclophilin
includ
role
regul
protein
fold
function
molecular
chaperon
activ
cypa
modul
cell
signal
transduct
helper
type
cytokin
product
accumul
evid
suggest
role
cyclophilin
mediat
intercellular
commun
via
extracellular
sourc
protein
member
cyclophilin
famili
notabl
cyclophilin
b
cypb
contain
endoplasm
reticulum
er
direct
signal
sequenc
promot
secret
inde
cypb
detect
readili
human
milk
plasma
cypb
also
releas
chondrocyt
activ
mmp
cyclophilin
cypa
shown
secret
cell
respons
inflammatori
stimuli
oxid
stress
activ
platelet
also
demonstr
secret
cypa
unlik
cypb
cypa
contain
prototyp
signal
peptid
found
protein
undergo
secret
classic
pathway
instead
mechan
cypa
secret
shown
recent
proceed
via
vesicular
pathway
studi
cypa
found
local
plasma
membran
vascular
smooth
muscl
cell
follow
reactiv
oxygen
speci
ro
stimul
secret
cypa
protein
detect
within
min
stimul
apart
cypa
cypb
member
cyclophilin
famili
shown
secret
activ
although
possibl
remain
intracellular
cyclophilin
becom
extracellular
due
protein
releas
dead
die
cell
activ
site
residu
cyclophilin
demonstr
critic
signal
chemotact
activ
induc
protein
exampl
peptidylprolyl
cistran
isomerasedefect
cypa
mutant
fail
initi
signal
event
suggest
unusu
rotamasedepend
mechan
signal
receptor
mode
signal
requir
transient
interact
ligand
receptor
consist
lowaffin
bind
interact
cypa
inde
demonstr
recent
cypa
catalys
peptidylprolyl
cistran
isomer
see
similarli
cypb
also
shown
enzymat
activ
although
case
catalys
residu
identifi
import
note
signal
chemotact
activ
cypa
cypb
also
depend
upon
presenc
heparan
sulphat
proteoglycan
hspg
probabl
serv
primari
bind
site
cyclophilin
target
cell
remov
hspg
cell
surfac
neutrophil
elimin
signal
respons
cyclophilin
abolish
cyclophilindepend
chemotaxi
adhes
neutrophil
cell
interestingli
activ
cell
shown
remov
depend
cypaspecif
respons
heparan
suggest
increas
express
andor
dimer
activ
cell
may
substitut
heparan
enhanc
cypa
bind
result
support
model
wherebi
cyclophilin
bind
hspg
requir
complement
lowaffin
interact
cyclophilin
express
nonactiv
cell
importantli
rotamas
activ
cyclophilin
influenc
hspg
express
cell
surfac
multifunct
molecul
addit
activ
describ
cyclophilin
receptor
induc
mmp
also
affect
activ
develop
cell
regul
transport
monocarboxyl
transport
mct
plasma
membran
contribut
bloodbrain
barrier
function
cerebr
endotheli
cell
interestingli
differ
activ
appear
involv
differ
domain
consist
amino
acid
extracellular
region
contain
two
iglik
domain
aa
residu
transmembran
domain
aa
cytoplasm
domain
fig
extracellular
region
contain
three
nlink
glycosyl
site
extracellular
portion
quit
divers
residuelong
transmembran
domain
repres
hydrophob
stretch
amino
acid
interrupt
charg
residu
glutam
acid
almost
ident
among
differ
speci
structur
featur
transmembran
domain
suggest
potenti
addit
function
role
besid
anchor
membran
charg
residu
usual
found
protein
span
membran
case
charg
residu
middl
lipid
bilay
highli
energet
unfavour
thu
propens
form
complex
membran
protein
therebi
shield
charg
energet
stabl
state
inde
transmembran
domain
respons
mani
interact
transmembran
protein
includ
integrin
syndecan
fig
interact
may
contribut
activ
leucocyt
adhes
may
also
involv
signal
respons
inde
recent
studi
demonstr
cytoplasm
domain
requir
extracellularregul
kinas
erk
activ
key
signal
event
initi
interact
provid
support
involv
transmembran
protein
signal
transduct
shown
interact
sever
protein
tabl
exampl
interact
mct
protoncoupl
transport
monocarboxyl
occur
within
cellular
membran
depend
critic
upon
describ
central
posit
glutam
acid
residu
transmembran
domain
associ
monocarboxyl
transport
disrupt
mutat
glutam
acid
neither
reach
plasma
membran
suggest
might
part
heteromer
membran
complex
involv
mct
support
notion
recent
studi
show
associ
basolater
membran
suggest
complex
interact
may
regul
cell
migrat
modul
focal
adhes
also
interact
cell
surfac
interact
seem
regul
cluster
activ
neg
thu
exert
tumoursuppress
activ
convers
sever
report
suggest
carcinogen
activ
via
upregul
glycosyl
link
mmp
induct
tumour
invas
associ
depend
upon
second
ig
domain
extracellular
portion
final
leucin
along
adjac
amino
acid
cytoplasm
domain
identifi
signal
target
basolater
membran
extraocular
epithelia
delet
amino
acid
result
mistarget
apic
membran
signal
seem
function
cell
type
eg
recogn
human
retin
pigment
epithelium
cell
suggest
mediat
interact
limit
cellspecif
regul
protein
traffick
futur
studi
hope
integr
find
unifi
model
traffick
model
suggest
new
target
therapeut
intervent
diseas
recogn
pathogen
factor
eg
cancer
rheumatoid
arthriti
ra
also
explain
role
biolog
process
develop
eye
spermatogenesi
addit
cypa
cypb
cell
initi
signal
respons
character
ca
flux
activ
kinas
genet
analysi
demonstr
amino
acid
pro
gli
critic
signal
addit
pro
involv
interact
anoth
cyclophilin
regul
cell
surfac
express
pro
locat
either
near
end
transmembran
domain
face
outsid
cell
may
partial
expos
access
extracellular
cyclophilin
inde
nuclear
magnet
reson
nmr
studi
recombin
protein
reveal
cypamedi
isomer
stabil
rare
cisconform
trp
pro
peptidylprolyl
bond
potenti
repres
prolin
switch
thu
interact
may
repres
first
discov
ligandreceptor
interact
prolin
isomer
outsid
cell
result
intracellular
signal
insid
cell
although
direct
interact
cypa
found
may
mediat
involv
sequest
cyclophilin
site
way
ternari
interact
cypa
form
ternari
complex
calcineurin
calcineurin
inhibitor
cyclosporin
suggest
complex
array
interact
may
underli
signal
therefor
interact
cyclophilin
pro
may
necessari
bind
wherea
subsequ
interact
pro
induc
signal
transduct
signal
induc
homotyp
interact
molecul
mechan
cyclophilininduc
signal
remain
unknown
addit
molecul
associ
directli
indirectli
appear
involv
signal
cytoplasm
tail
necessari
cypainduc
erk
activ
ad
complex
issu
remain
determin
whether
erk
activ
fact
requir
chemotact
respons
mediat
interact
whether
signal
pathway
involv
differ
domain
involv
mmp
induct
chemotact
respons
domain
may
close
due
intermolecular
interact
mediat
bend
molecul
due
interact
ig
domain
would
explain
singl
monoclon
antibodi
clone
inhibit
mmp
induct
chemotact
respons
unpublish
observ
stimul
mmp
product
occur
via
heterotyp
cell
interact
tumour
cell
fibroblast
homotyp
cell
interact
potenti
repres
cyclophilinindepend
mean
signal
fact
multipl
extracellular
form
identifi
includ
fulllength
associ
larg
microvesicl
continu
stimul
secret
mmp
proinflammatori
cytokin
interestingli
entir
ectodomain
well
individu
iglik
domain
cleav
cell
surfac
mani
exactli
mmp
secret
due
stimul
stimulatori
activ
extracellular
peptid
demonstr
recent
recombin
ectodomain
compris
iglik
domain
residu
shown
stimul
secret
mmp
proinflammatori
cytokin
first
iglik
domain
fig
nlink
glycosyl
respons
mmpstimul
activ
howev
occur
remain
unknown
exampl
iglik
domain
appear
associ
directli
even
millimolar
concentr
suggest
protein
interact
may
mediat
propos
homophil
associ
ad
complex
domain
found
form
highli
stabl
swap
dimer
one
ctermin
betastrand
residu
fold
structur
monom
fig
although
appear
mediat
two
prolin
cistran
isomer
current
evid
cypa
cyclophilin
mediat
interact
isomer
occur
spontan
solut
thu
swap
occur
whether
cypa
involv
whether
domainswap
underli
homophil
interact
remain
seen
domainswap
may
turn
result
conform
chang
interact
protein
similar
cadherin
famili
howev
unlik
cadherin
evid
monomerdim
equilibrium
extracellular
form
found
monomer
thu
domainswap
repres
either
misfold
form
rare
occur
recombin
iglik
domain
may
mediat
activ
induc
domainswap
subsequ
signal
regard
intracellular
signal
associ
cyclophilinindepend
activ
experi
purifi
ad
fibroblast
stimul
transcript
demonstr
critic
role
mitogenactiv
protein
kinas
mapk
activ
whether
activ
mediat
signal
origin
cytoplasm
tail
protein
remain
unknown
contrast
product
fibroblast
shown
depend
upon
phospholipas
pathway
mapk
activ
appear
differ
signal
pathway
lead
mmp
induct
initi
suggest
complex
regul
probabl
involv
two
kind
signal
molecul
associ
directli
cytoplasm
tail
associ
indirectli
via
bridg
protein
given
multipl
partner
activ
surpris
protein
implic
pathogenesi
number
diseas
exampl
might
also
repres
univers
coreceptor
viral
entri
host
cell
shown
enhanc
infect
human
immunodefici
viru
sever
acut
respiratori
syndrom
sar
coronaviru
addit
recent
report
identifi
crucial
part
multiprotein
gsecretas
complex
complex
cleav
bamyloid
precursor
protein
produc
amyloid
bpeptid
associ
format
amyloid
plaqu
alzheim
diseas
patient
surpris
pathogen
effect
relat
either
mmp
induct
capac
mediat
chemotact
activ
extracellular
cyclophilin
could
activ
suffici
obviou
contribut
significantli
diseas
pathogenesi
probabl
simpli
know
enough
make
connect
beststudi
activ
role
cancer
activ
link
tightli
induct
mmp
promot
tissu
destruct
facilit
tumour
metastasi
role
cancer
topic
mani
studi
review
stimul
mmp
product
stromal
fibroblast
endotheli
cell
around
tumour
well
tumour
cell
mechan
involv
homophil
interact
molecul
oppos
cell
elev
level
detect
numer
malign
tumour
shown
correl
tumour
progress
experiment
clinic
condit
recent
propos
novel
marker
poor
outcom
serou
ovarian
hepatocellular
carcinoma
advanc
bladder
cervic
cancer
lung
adenocarcinoma
gallbladd
carcinoma
mmpinduc
function
also
known
contribut
significantli
tissu
repair
remodel
cancer
develop
well
sever
patholog
condit
review
recent
notabl
shown
promot
tissu
remodel
induc
express
asmooth
muscl
actin
model
cardiovascular
diseas
corneal
wound
heal
suggest
function
may
tissuespecif
well
mmpspecif
interestingli
evid
link
cancerpromot
activ
interact
extracellular
cyclophilin
extracellular
cypa
shown
stimul
prolifer
lung
cancer
cell
line
induc
signal
activ
shown
previous
mediat
similar
proliferationpromot
activ
cypa
shown
human
pancreat
cancer
cell
cypa
activ
pathway
exact
mechan
prolif
activ
role
pathogenesi
cancer
remain
unclear
await
confirm
although
requir
upregul
level
mediat
mmp
induct
demonstr
formal
mani
patholog
condit
involv
inflammatori
compon
associ
increas
express
tissu
cell
includ
lung
inflammatori
diseas
ra
system
lupu
erythematosu
sle
chronic
liver
diseas
induc
hepat
c
viru
hcv
atherosclerosi
ischaemia
high
level
extracellular
cyclophilin
also
detect
sever
differ
human
inflammatori
diseas
sever
sepsi
vascular
smooth
muscl
cell
diseas
atherosclerosi
lupu
lyme
diseas
ra
note
list
diseas
increas
cyclophilin
level
overlap
diseas
upregul
suggest
cyclophilin
via
interact
may
contribut
recruit
immun
cell
site
inflamm
via
chemokinelik
activ
exampl
level
cypa
synovi
fluid
isol
ra
patient
report
correl
number
neutrophil
present
within
synovi
space
well
diseas
sever
anoth
studi
cartilag
chondrocyt
shown
secret
cyclophilin
respons
matrix
metalloproteinas
stimuli
provid
addit
sourc
extracellular
cyclophilin
releas
ongo
ra
interestingli
studi
look
proinflammatori
leucocyt
report
increas
express
cell
surfac
cell
rel
noninflammatori
cell
exampl
upregul
express
observ
synovi
membran
well
circul
synovi
monocytesmacrophag
ra
patient
increas
level
also
report
recent
murin
synovi
fibroblast
cell
line
use
studi
cartilag
invas
destruct
one
might
postul
increas
express
would
enhanc
interact
leucocyt
extracellular
cyclophilin
therebi
promot
recruit
support
report
recent
activ
cell
show
enhanc
cyclophilinmedi
chemotaxi
correl
upregul
express
recent
studi
sever
anim
model
human
diseas
underscor
import
role
interact
diseas
pathogenesi
studi
use
mous
model
lipopolysaccharid
lp
induc
acut
lung
inflamm
demonstr
treatment
either
mab
nonimmunosuppress
csa
analogu
reduc
inflammatori
respons
significantli
treatment
led
inhibit
neutrophilia
within
lung
tissu
airway
importantli
treat
mice
combin
mab
csa
led
inhibit
neutrophil
infiltr
slightli
greater
induc
individu
treatment
indic
csa
probabl
act
interact
also
demonstr
mous
model
acut
asthmat
inflamm
vivo
treatment
mab
reduc
significantli
accumul
eosinophil
effector
memori
lymphocyt
well
antigenspecif
cytokin
secret
pulmonari
airway
tissu
allergen
challeng
mice
treatment
also
reduc
significantli
airway
epitheli
mucin
product
bronchial
hyperreact
methacholin
challeng
collageninduc
arthriti
mous
model
human
ra
vivo
treatment
mab
inhibit
develop
joint
inflamm
factor
associ
presenc
proinflammatori
leucocyt
includ
tumour
necrosi
factor
tnf
myeloperoxidas
also
reduc
significantli
suggest
treatment
impact
leucocyt
recruit
joint
find
consist
recent
report
demonstr
alon
combin
antitnfa
inhibit
cartilag
eros
synov
sever
combin
immunodefici
scid
mous
model
ra
describ
mmp
play
import
role
pathogenesi
mani
diseas
includ
inflammatori
condit
evid
extracellular
cyclophilin
probabl
via
interact
may
contribut
mmp
product
report
seizer
coauthor
studi
atherosclerosi
apolipoprotein
e
apo
defici
mous
model
demonstr
silenc
express
sirna
cell
differenti
process
hinder
upregul
mmp
presenc
cyclophilin
inhibitor
also
reduc
secret
significantli
differenti
process
convers
presenc
cypa
enhanc
secret
matur
foam
cell
cypa
found
consist
atherosclerot
plaqu
apoedefici
mice
result
suggest
pathway
may
play
relev
role
promot
vulner
atherosclerot
plaqu
thu
contribut
pathogenesi
atherosclerosi
similar
effect
report
yang
et
al
human
ra
demonstr
cypa
increas
vitro
product
activ
monocytesmacrophag
deriv
ra
synovi
fluid
wherea
antibodi
decreas
observ
express
dramat
therefor
mmp
upregul
may
anoth
mechan
interact
might
contribut
ra
pathogenesi
promot
cartilag
destruct
given
role
interact
play
pathogenesi
inflammatori
diseas
present
attract
target
therapeut
intervent
agent
potenti
disrupt
interact
interact
group
agent
target
drug
target
cyclophilin
agent
may
also
use
treatment
diseas
involv
cyclophilin
andor
cancer
hiv
infect
inhibit
use
monoclon
antibodi
provid
reduct
inflamm
mous
model
acut
lung
inflamm
asthma
ra
therapeut
use
antagonist
antibodi
would
prevent
cyclophilininduc
signal
mmpinduc
activ
interestingli
site
respons
two
function
appear
adjac
secondari
structur
may
possibl
inhibit
function
singl
monoclon
antibodi
c
b
unpublish
observ
futur
clinic
applic
would
necessari
ensur
antibodi
exert
agonist
activ
may
compromis
therapeut
effect
attract
approach
inhibit
activ
via
antagonist
peptid
deriv
extracellular
domain
acid
peptid
shown
inhibit
mmp
product
invas
synoviocyt
ra
patient
product
invas
potenti
pmadifferenti
cell
human
monocyt
leukaemia
cell
line
infect
host
cell
sar
coronaviru
report
yet
shown
vivo
activ
peptid
anim
model
human
diseas
yet
anoth
possibl
way
target
downregul
express
use
rnai
approach
techniqu
work
use
vitro
suppress
cell
prolifer
invas
metastat
activ
cancer
cell
induc
apoptosi
use
clinic
applic
await
studi
anoth
arm
axi
cyclophilin
cyclophilintarget
drug
csa
use
mani
year
immunosuppressor
obvious
immunosuppress
activ
would
unwant
complic
clinic
use
drug
antiinflammatori
anticanc
agent
furthermor
chemotaxi
inflammatori
cell
depend
upon
activ
extracellular
cyclophilin
need
inhibit
calcineurin
function
suppress
cyclophilindepend
chemotaxi
studi
demonstr
nonimmunosuppress
csa
deriv
exert
potent
antiinflammatori
activ
compar
unmodifi
csa
mous
model
acut
lung
inflamm
even
excit
recent
report
describ
modif
introduc
csa
molecul
make
unabl
penetr
cell
membran
still
retain
cyclophilinbind
activ
nonperm
csa
deriv
use
mous
model
acut
lung
inflamm
show
extrem
potent
antiinflammatori
activ
significantli
exceed
nonperm
csa
like
advers
effect
appear
ideal
candid
develop
antiinflammatori
drug
treat
diseas
ra
asthma
atherosclerosi
taken
togeth
result
show
import
contribut
interact
initi
andor
progress
inflammatori
respons
via
recruit
leucocyt
inflam
tissu
stimul
mmp
product
show
great
potenti
therapeut
target
interact
treatment
inflammatori
diseas
base
upon
variou
studi
review
clear
cyclophilin
multifunct
properti
independ
interact
complex
number
mechanist
detail
interact
cyclophilin
still
unknown
await
studi
particular
would
extrem
import
refin
understand
cyclophilininduc
signal
isomer
initi
intracellular
signal
site
besid
involv
signal
respons
cyclophilin
signal
involv
protein
signal
pathway
initi
cyclophilin
signal
transduct
mechan
pathway
answer
question
would
essenti
futur
translat
effort
aim
target
pathway
inde
demonstr
molecul
interact
play
direct
role
differ
type
inflammatori
condit
provid
attract
new
target
intervent
although
reagent
block
either
cyclophilin
function
shown
effect
reduc
inflammatori
respons
experiment
model
diseas
specif
reagent
still
quit
broad
multipl
function
cyclophilin
probabl
inhibit
current
challeng
design
therapeut
agent
capac
block
specif
function
molecul
leav
function
unaffect
context
recent
studi
report
develop
smallmolecul
compound
capac
specif
inhibit
function
cypa
without
effect
cypb
activ
similar
approach
investig
develop
reagent
impact
select
function
exampl
target
differ
domain
molecul
progress
endeavour
provid
new
treatment
opportun
mani
inflammatori
diseas
includ
ra
asthma
may
also
contribut
treatment
diseas
atherosclerosi
cancer
